Ethics and transparency
navigate_next Compliance navigate_next
The EFPIA Code (Code on Transparency of Value Transfers between Pharmaceutical Companies, Health Care Professionals, and Health Care Organizations)
Based on the ethical principles that guide its actions and to meet the increasingly pressing and ongoing expectations for legality and transparency expressed by both citizens and institutions, Savio Pharma Italia, a division of IBN Savio s.r.l., has wholeheartedly adhered to the EFPIA Code (European Federation of Pharmaceutical Industries and Associations), the contents of which have been incorporated into the Farmindustria Code of Ethics.
The correct and positive relationship established between the pharmaceutical industry and healthcare professionals (HCP: Healthcare Professionals) and/or healthcare organizations (HCO: Healthcare Organisations) has always led to the research and development of innovative therapies, useful for safeguarding one of the rights fundamentals of Citizens and constitutionally guaranteed, i.e. the right to health. In fact, it is worth highlighting that the Transfers of Value between the pharmaceutical industry and the medical community, to which the EFPIA Code refers, cannot and must not be considered exclusively as transfers of an economic nature; they also allow the mutual transfer of a much more important value which is that of scientific knowledge, to the full advantage of Citizens/Patients.
he cooperation between pharmaceutical Industry, healthcare Operators and healthcare Organisations, already well regulated by the current legislation, becomes even more transparent thanks to the application of the EFPIA Code.
The further transparency of relationship, will consolidate the foundation on which future collaborations will be developed and will lead to further benefits for Citizens/Patients who, having the opportunity to know the contents of this relationship, will be able to:
– undergo, with greater confidence and awareness, the therapies that will be offered to them;
– dispel the prejudices and fears always present in Public Opinion when economic relationships (Value Transfers) are referred to in the Health Care System.
Transfers of Value
As of January 1, 2026, following a merger, Savio Pharma Italia was incorporated into I.B.N. Savio S.r.l., effectively becoming a division of the company.
SAVIO Pharma Italia, a division of IBN Savio s.r.l., therefore undertakes to publish annually on its company website all direct or indirect financial transfers, both in cash and in kind (Transfers of Value), made in the previous year to Healthcare Professionals and/or Healthcare Organizations.
The Transfers of Value, which data publication is requested for, are those relative to the participation to Events (Conventions, Congresses, Visits to production plants…), consulting and professional services, donations and contributions, research and development (clinical, non-clinical and prospective observational studies).
Data are published on an individual basis. Nell’eventualità che l’Operatore avesse negato la formale autorizzazione alla pubblicazione dei propri dati, in osservanza della normativa sulla privacy, la SAVIO PHARMA ITALIA S.r.l., Divisione di IBN Savio s.r.l.,ha provveduto alla pubblicazione degli stessi in forma aggregata. All Value Transfers are reported in Euros (€). Payments made, for example, for services, sponsorships, contributions, donations, and other services in general are recognized on an accrual basis (calendar year) and are normally reported net of VAT. In the event that withholding is to be made for income tax purposes, the amount of the withholding is included. Other types of payments such as those made for services related to Travel and Hospitality (travel tickets, hotel, etc.) are to be understood gross of VAT to the extent required by law.
The Code of Ethics of Farmindustria
Savio Pharma Italia, a division of IBN Savio s.r.l., believes it is necessary to establish an ethical, loyal and transparent relationship with its interlocutors: be they healthcare professionals, institutions, citizens, collaborators, commercial partners.. With this in mind, the Company operates in compliance with applicable laws and regulations, professional ethics, and internal regulations; it is associated with Farmindustria and fully adheres to the contents of this association’s CODE OF ETHICS.
RELATIONSHIP WITH PATIENT ASSOCIATIONS
SAVIO Pharma Italia, in compliance with the indications of the Code of Ethics of Farmindustria, makes public the list of the Patient Associations it supported in the previous year, together with the purposes underlying such support and the economic value of the funding provided to each Association.
For the year 2023, please consult the appropriate TABLE
Code of Conduct and MOMC ex Legislative Decree n. 231/2001
The pursuit of the interests of Savio Pharma Italia, a Division of IBN Savio s.r.l., can never justify conduct contrary to the principles of honesty, fairness, legitimacy, and transparency. To this end, the Company’s Administrative Body has adopted the Code of Conduct which, in addition to identifying the reference ethical standards, highlights the set of rights, duties and responsibilities of all those who, in any capacity, operate therein , whether they are employees, consultants or in any case subjects linked by a collaborative relationship. Il Codice di Comportamento svolge un ruolo fondamentale nel mantenere questi principi. Infatti, Savio Pharma Italia, Divisione di IBN Savio s.r.l., si impegna a diffonderne il contenuto a quanti entrano in relazione con essa e richiede il rispetto di tale Codice da parte dei propri dipendenti, ISF, consulenti e/o collaboratori. The Code of Conduct also constitutes a governance tool and is an integral part of the company’s “Organization, Management and Control Model” for the protection from offenses as provided for in the Legislative Decree. no. 231/2001 regarding the administrative responsibility of the Company.